Developing vaccines for neglected and emerging infectious diseases
- PMID: 33568361
- DOI: 10.1136/bmj.n373
Developing vaccines for neglected and emerging infectious diseases
Conflict of interest statement
Competing interests: I have read and understood BMJ policy on declaration of interests and declare I have received research funding from Gavi, the Vaccine Alliance (Gavi), which supports epidemic and pandemic vaccine deployment, and the Bill & Melinda Gates Foundation, which funds vaccine research and development for neglected and emerging infections. I was a member of the World Bank’s COVID-19 Vaccine Development Taskforce and Gavi’s working group to develop COVAX. I coauthored a proposal to launch an aggregator for late stage trials of neglected disease product development. Provenance and peer review: Commissioned; not externally peer reviewed.
Comment in
-
How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?BMJ. 2021 Mar 10;372:n678. doi: 10.1136/bmj.n678. BMJ. 2021. PMID: 33692023 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical